Celsee, Inc. Enters into Supply Agreement with Argonaut Manufacturing Services

Carlsbad, CA, 02/14/18 – Argonaut Manufacturing Services, a contract manufacturing organization (CMO) serving the life science and molecular diagnostics markets, announced today it has entered into a supply agreement with Celsee, Inc. (“Celsee”), an innovator of comprehensive circulating tumor cell (CTC) and single cell preparation & analysis products. Under the terms of the agreement, Argonaut will manufacture and assemble kits and reagents for Celsee, Inc. for use in their research & development, clinical research, and commercial systems effective the second quarter of 2018.

“The promise of clinical applications using single cell analysis are vast,” said Wayne Woodard, CEO of Argonaut. “Argonaut is eager to support the innovators in this space and Celsee’s leadership in pushing the boundaries is inspiring. We look forward to accomplishing great things together.”

“The inherent flexibility built into Argonaut’s manufacturing processes gives Celsee immediate scalability at an affordable cost,” said John Stark, CEO of Celsee. “Their QC systems gives us instant access into their manufacturing pipeline so we can make quick decisions. Interfacing our requirements with Argonaut’s Client Services team has been seamless.”

About Celsee

Celsee, Inc. develops, manufactures, and markets integrated comprehensive single-cell analysis solutions that provide an unprecedented combinational ability to accurately identify, analyze and viably retrieve single cells directly from blood and tissue. Celsee’s platforms provide a practical approach to accurately analyze previously undetectable or rare cells to a scale of millions of single cells from an individual sample. The patented approach incorporates the fundamental properties of gravity for the gentle capture and isolation of individual cells from heterogeneous blood and tissue suspensions. Celsee’s comprehensive single-cell analysis platforms offer a practical solution for understanding and monitoring cell-based diseases. For more information, visit www.celsee.com.

About Argonaut Manufacturing Services

Argonaut is an independent contract manufacturing organization dedicated to providing manufacturing and supply chain solutions for life science, medical technology, drug development, and molecular diagnostic companies. With 11 state-of-the-art manufacturing cleanroom suites located within their 31,000 square foot facility, Argonaut provides flexible solutions for diverse outsourcing needs. For more information, visit www.argonautms.com.

© Copyright Argonaut Manufacturing Services

Drug Product Fill/Finish

The world’s leading fill/finish technology is available for you in our facilities. Equipped with advanced robotics, our automated state-of-the-art line is specially designed to reduce risk and maximize fill yield.

Whitepapers

See our other thought-provoking white papers and get industry-leading insights.